As one of the first centres in the world to be accredited via BSAC’s Global Antimicrobial Stewardship Accreditation Scheme (GAMSAS), Lagos University Teaching Hospital, in Lagos, Nigeria, has received major news coverage in their home country, with their success reported by the Nigerian Television Authority (NTA).

BSAC is excited to announce the next tranche of hospitals that have been accredited via the Global Antimicrobial Stewardship Accreditation Scheme (GAMSAS) and congratulates the following hospitals on their achievements:

This December, BSAC will be hosting our annual in-person Antibiotic Resistance and Mechanisms (ARM) Workshop for Researchers at The Birmingham Conference & Events Centre, Birmingham, UK. Our 2023 workshop will offer members of the UK community researching mechanisms of antimicrobial resistance the opportunity to meet, to consolidate and extend the expertise held within individual laboratories in the United Kingdom. We caught up with Dr Ronan McCarthy, Senior Lecturer, Brunel University London and co-Chair of the ARM Programme Committee, to explain why ARM is such an important and unique event on the BSAC calendar.

Check out the Editors’ picks from Journal of Antimicrobial Chemotherapy and JAC-Antimicrobial Resistance. This month, we have insights into antibiotic prescribing, including the impact of the COVID-19 pandemic on European consumption, metrics for benchmarking usage in farms and baseline data from hospitals in Bhutan. Plus, read a systematic review of molnupiravir treatment for COVID-19 and a concerning report of Klebsiella pneumoniae resistant to novel antibiotics emerging in Italy.

The Pharmacists’ Defence Association (PDA) and the British Society for Antimicrobial Chemotherapy (BSAC) would like to respond to the flooding in Libya, the earthquake in Morocco – and the ongoing conflict in Ukraine – by expressing our solidarity with our colleagues and friends in the affected regions, and by reminding all relevant decisionmakers of the link between natural disaster, war, and the emergence and rapid spread of drug-resistant infections.

The British Society for Antimicrobial Chemotherapy (BSAC) and the Commonwealth Pharmacy Association (CPA) are excited to announce they have signed a Memorandum of Understanding (MOU) to establish a framework for collaborating on infection management and antimicrobial stewardship (AMS) activities. The MOU provides a launchpad for the parties to further their activities to promote the appropriate use of antibiotics and antimicrobial resistance (AMR) surveillance, ensure patient safety, and address and stem the proliferation of AMR to protect community health.

Here’s a selection of articles recently published in Journal of Antimicrobial Chemotherapy (JAC) and JAC-Antimicrobial Resistance (JAC-AMR), as chosen by the Editors-in-Chief. In JAC, we highlight updated antifungal prophylaxis recommendations, the importance of rapid microbiological results and how to measure antibiotic usage in low-income settings. And in JAC-AMR, learn about three very different approaches to antimicrobial resistance education.

The British Society for Antimicrobial Chemotherapy (BSAC) is collaborating with the University of Aberdeen Epidemiology Group to develop the first UK Antimicrobial Registry (UKAR) to provide information about the safety and efficacy of new antimicrobials in real-world use.